Test Bank for Integrated cardiopulmonary pharmacology 3rd edition by Bruce J Colbert Chapters 1-15 Covered

, Colbert_icp3_TestBank_questions



Test Bank
Integrated cardiopulmonary pharmacology
3rd edition by Bruce J Colbert
Chapters 1-15 Covered



TABLEOFCONTENT I I




PARTI:THEBASICS
I I I




1.GeneralPharmacologicPrinciples
I I I




2.TheMetricSystemandDrugDosageCalculations
I I I I I I I




3.PharmacologyoftheAutonomicNervousSystem
I I I I I I




4.MedicatedAerosolTreatments
I I I




PARTII:THESPECIFICDRUGCATEGORIES
I I I I I




5.Bronchodilators
I




6.MucokineticsandSurfactants
I I I




7.Anti-InflammatoryandAntiasthmaticAgents
I I I I




8.Anti-InfectiveAgents
I I




9.CardiacAgents
I I




10.BloodPressureandAntithromboticAgents
I I I I I




11.Neuromuscular,Sedative,Anesthetic,andAnalgesicAgents
I I I I I I




12.TherapeuticMedicalGases
I I I




PARTIII:PUTTINGITALLTOGETHER
I I I I I




Page1 of 148
I I I

, Colbert_icp3_TestBank_questions


13.PharmacologicManagementofObstructivePulmonaryDisease:Asthma,Chronic
I I I I I I I I




Bronchitis,andEmphysema
I I I




14.PharmacologicTreatmentofRespiratoryInfectiousDisease
I I I I I I




15.MedicationsforAdvancedCardiovascularLifeSupport
I I I I I I




Page2 of 148
I I I

, Colbert_icp3_TestBank_questions


TestBank
I




Chapter1MULTIPL I I




ECHOICE
I




Choosetheonealternativethatbestcompletesthestatementoranswersthequesti
I I I I I I I I I I I I




on.
1. Whichtermbestdescribesthestudyofdrugsandtheiractiononthebody?
I I I I I I I I I I I I I




a. Therapeutics
b. Pharmacology
c. Pharmacotherapy
d. Diseasemanagement I




2. Themostcommonsourceofdrugstodayis:
I I I I I I I




a. Plants.
b. Animals.
c. Chemicalsynthesis. I




d. Geneticbioengineering. I




3. Theagencythatregulatesdrugtestingandapprovesnewdrugsisthe:
I I I I I I I I I I I




a. CenterforDrugEvaluationandResearch(CDER). I I I I I I




b. CentersforDiseaseControlandPrevention(CDC). I I I I I I




c. NationalInstitutesofHealth(NIH). I I I I




d. FoodandDrugAdministration(FDA). I I I I




4. Thephaseofdrugtestingthatisperformedtolookforrareorseriousadverse
I I I I I I I I I I I I I I I




effectsafterthedrugismarketedis:
I I I I I I




a. PhaseI. I




b. PhaseII. I




c. PhaseIII. I




Page3 of 148 I I I